Covance

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

PPD rumored to be in exclusive acquisition talks with D.C.-based private equity firm the Carlyle Group

Monday, August 22, 2011 08:02 AM

While many in the upper echelon of private equity investors have been courting CRO PPD, for now all but one have been shooed away: Washington, D.C.-based Carlyle Group.

More... »

CROs using backlog numbers to put positive spin on less-than-stellar quarterly earnings reports

Monday, August 22, 2011 08:00 AM

Using backlog allows CROs to put a positive spin on what otherwise might be less-than-stellar earnings; while they may not have had the healthiest quarter—or year—financially, they can showcase all of the work that has been promised over the next few quarters in millions, or billions, of dollars.

More... »

Covance enters agreement to acquire TRAC Microbiology

Thursday, August 11, 2011 01:35 PM

Covance has entered into a definitive agreement to acquire TRAC Microbiology, a Madison, Wisconsin-based food microbiology and chemistry laboratory. TRAC provides testing, research, auditing, and consulting services to clients ranging from small family businesses to large food-based corporations.

More... »

Covance collaborates with Broad Institute, expands drug metabolism services

Thursday, August 4, 2011 11:54 AM

Covance said that its Seattle-based genomics laboratory will collaborate with the Broad Institute to create genomic resources for an important research model. Covance’s Next-Generation sequencing capabilities will be used to profile microRNA expression in various tissue samples from this model.

More... »

Premier Research Groups names VP of human resources

Monday, August 1, 2011 12:44 PM

Premier Research Group has named Mark P. Sneff vice president, human resources. In this role, Sneff will be responsible for the global human resources function and staff in support of Premier Research’s strategic goals.

More... »

PPD denies CRO merger rumors, but stays mum on possibility of private equity takeover

Monday, July 25, 2011 08:00 AM

In the wake of last week’s Wall Street Journal report claiming PPD might be putting itself on the block, the top-tier CRO responded with a statement that it is not discussing mergers with other CROs. But what about private equity firms?

More... »

PPD shares rise on takeover rumors

Monday, July 18, 2011 01:51 PM

Shares of CRO Pharmaceutical Product Development (PPD) rose 16% to levels not touched in more than two-and-a-half years on Monday, a day after a Wall Street Journal report said the company was looking to sell itself, reported Reuters.

More... »

Covance Q1 income above average

Friday, May 6, 2011 11:56 AM

U.S.-based drug development CRO Covance’s net revenues for the first-quarter of 2011 were $502 million, above the average analyst forecast, according to Pharma Times.

More... »

CRO Cetero appoints James Dixon as SVP

Tuesday, April 26, 2011 02:07 PM

North Carolina-based CRO Cetero Research has appointed James "Jay" Dixon to senior vice president, quality and compliance. Dixon has spent more than 25 years in the pharmaceutical, biotechnology and CRO industries.  

More... »